
Nifty Pharma Prediction for Tomorrow: 18 September 2026 Outlook (Including F&O)
Updated: 17 Sept 2026 • 4:29 pm
Posted by:

Click Here – Get Free Investment Predictions
Nifty Pharma closed at 26,579.25, up 1.66%. Sun Pharmaceutical Industries gained 0.74%. India VIX 12.14.
Quick Answer: The nifty pharma prediction for tomorrow is cautiously positive for 18 September 2026. Sun Pharmaceutical Industries, a key constituent, gained 0.74 percent on 17 September 2026, tracking broader Nifty 50 direction and F&O positioning.
The nifty pharma prediction for tomorrow is in focus after Nifty Pharma closed at 26,579.25 on 17 September 2026, up 1.66 percent. Pharma stocks led sectoral gains today, up sharply as investors rotated into the sector
Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are watching sector-specific triggers here, alongside the broader Nifty 50 and Sensex direction heading into 18 September 2026.
Also read – Stock Market Predictions for Tomorrow, 18 September 2026
Today's Sector Recap
- Sun Pharmaceutical Industries gained 0.74 percent, among the key movers in this space on 17 September 2026.
- The broader Nifty 50 closed at 23,270.60, up 0.23 percent, setting a cautious tone across most sectors.
- India VIX rose to 12.14, indicating a mild pickup in near-term volatility expectations.
Nifty Pharma F&O Outlook for Tomorrow
For traders active in F&O, this outlook will hinge on open interest build-up and rollover activity in Nifty Pharma futures and options contracts into 18 September 2026. Kunal Singla notes that a stable to falling India VIX would support range-bound F&O positioning, while a further rise could see wider intraday swings.
Key Drivers for Tomorrow
- Pharma stocks led sectoral gains today, up sharply as investors rotated into the sector
- Crude oil eased further, down over 1.6 percent on mcx, as the market pared back more of the earlier risk premium tied to this week's geopolitical tensions, a theme weighing on broader market sentiment.
- India vix plunged 7.82 percent, its sharpest single-day drop this month, as fear from the week's earlier turbulence unwound, with sector rotation into pharma, auto and metal even as banking pulled back mildly after a strong recent run.
Stocks to Watch for Tomorrow
| Stock | CMP | Relevance |
|---|---|---|
| Sun Pharmaceutical Industries | See Univest Screener | Key Nifty Pharma constituent |
| Apollo Hospitals Enterprise | See Univest Screener | Additional Nifty Pharma name to track |
Explore Nifty Pharma Stocks on Univest Screeners
Risks to This Prediction
- A sharper than expected move in crude oil prices could shift sentiment across all sectors, including Nifty Pharma.
- Stock-specific news flow in Sun Pharmaceutical Industries or other constituents could override the broader sector trend.
- A spike in India VIX could widen intraday ranges beyond the levels discussed here.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Conclusion
The nifty pharma prediction for tomorrow leans cautiously positive into 18 September 2026, with Sun Pharmaceutical Industries and broader Nifty 50 direction as the key variables. Ankit Jaiswal and Kunal Singla will revisit this view once tomorrow's opening trade confirms direction.
Also read – Nifty 50 Prediction for Tomorrow, 18 September 2026
Disclaimer: Investments and trades in securities and commodities are subject to market risk. Read all related documents carefully before investing. The information provided here is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.
FAQs
What is the nifty pharma prediction for tomorrow?
Ans. It is cautiously positive, based on Sun Pharmaceutical Industries's gain of 0.74 percent on 17 September 2026 and the broader Nifty 50 trend.
Which stocks matter most for this sector's outlook tomorrow?
Ans. Sun Pharmaceutical Industries is one of the key stocks to track, along with the broader Nifty 50 and Sensex direction.
Why did Nifty Pharma rally sharply today?
Ans. Nifty Pharma rallied 1.66 percent today, the strongest sectoral performer, as investors rotated into the sector alongside India VIX's sharp fall.
Should traders take F&O positions based on this outlook?
Ans. Any F&O position based on this outlook should factor in position sizing and stop-loss discipline, given the current uptick in India VIX.
Recent Articles

Crude Oil Prediction for Tomorrow: 18 September 2026 Price Outlook
17 September 2026

Silver Prediction for Tomorrow: 18 September 2026 Price Outlook
17 September 2026

Gold Prediction for Tomorrow: 18 September 2026 Price Outlook
17 September 2026

Bank Nifty Prediction for Tomorrow: 18 September 2026: Levels and Bank Stocks to Watch
17 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Crude Oil Prediction for Tomorrow: 18 September 2026 Price Outlook
Silver Prediction for Tomorrow: 18 September 2026 Price Outlook
Gold Prediction for Tomorrow: 18 September 2026 Price Outlook
Bank Nifty Prediction for Tomorrow: 18 September 2026: Levels and Bank Stocks to Watch
Sensex Prediction for Tomorrow: 18 September 2026: Levels, Movers and Stocks to Watch
Popular this week
Nifty 50 Prediction for Tomorrow: 18 September 2026: Support, Resistance and Stocks to Watch

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





